Protease-Activated Receptor-2 (PAR2)-A Novel Therapeutic Target in Nonalcoholic Steatohepatitis (NASH)

被引：0
|
作者：
Shearer, Andrew M. [1 ,2 ]
Austin, Karyn [2 ]
Guha, Srijoy [2 ]
Nga Nguyen [2 ]
Looby, Richard [3 ]
Clappin, Allyson [3 ]
Baleja, James [1 ]
Covic, Lidija [1 ,2 ]
Kuliopulos, Athan [1 ,3 ]
机构：
[1] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA
[2] Tufts Med Ctr, MORI, Boston, MA USA
[3] Oasis Pharmaceut, Lexington, MA USA
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
803
引用
收藏
页码：587A / 587A
页数：1
相关论文
共 50 条
  • [1] Protease-activated receptor-2 (PAR2) in the airways
    Cocks, TM
    Moffatt, JD
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2001, 14 (03) : 183 - 191
  • [2] Protease-activated Receptor-2 (PAR2) in Human Periodontitis
    Holzhausen, M.
    Cortelli, J. R.
    Araujo da Silva, V.
    Nobre Franco, G. C.
    Cavalca Cortelli, S.
    Vergnolle, N.
    JOURNAL OF DENTAL RESEARCH, 2010, 89 (09) : 948 - 953
  • [3] Protease-activated receptor-2 (PAR2) in cardiovascular system
    Bucci, M
    Roviezzo, F
    Cirino, G
    VASCULAR PHARMACOLOGY, 2005, 43 (04) : 247 - 253
  • [4] Protease-activated receptor-2 (PAR-2) as a potential therapeutic target
    Kanke, T
    Takizawa, T
    Kabeya, M
    Kawabata, A
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 64P - 64P
  • [5] Protease activated receptor-2 (PAR2): possible target of phytochemicals
    Kakarala, Kavita Kumari
    Jamil, Kaiser
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2015, 33 (09): : 2003 - 2022
  • [6] Pepducin - A Novel Protease-Activated Receptor-2 (par2) Inhibitor - Attenuates Experimental Pulmonary Hypertension
    Warburton, R.
    Kuliopulos, A.
    Wieschhaus, A.
    Kayyali, U. S.
    Toksoz, D.
    Fanburg, B. L.
    Preston, I. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [7] Does protease-activated receptor-2 (PAR2) influence muscle development and regeneration?
    Esfandouni, N. Taghavi
    Mackie, E.
    Pagel, C.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S218 - S219
  • [8] Predictive value of protease-activated receptor-2 (PAR2) in cervical cancer metastasis
    He, Shengnan
    Xu, Meiquan
    Xiong, Zhen
    Hu, Ye
    Huo, Qin
    Lu, Jingxiao
    Lin, Yuntao
    Yang, Lan
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (03) : 1415 - 1424
  • [9] Metabolomic analyses reveal a novel role for Protease Activated Receptor-2 (PAR2) in driving steatosis in Non-Alcoholic Steatohepatitis (NASH)
    Rana, Rajashree
    Shearer, Andrew M.
    Calnan, Conor
    Nga Nguyen
    Fynn, Laura
    Huang, Tianfang
    Baleja, James
    Covic, Lidija
    Kuliopulos, Athan
    HEPATOLOGY, 2016, 64 : 568A - 568A
  • [10] Toward Drugs for Protease-Activated Receptor 2 (PAR2)
    Yau, Mei-Kwan
    Liu, Ligong
    Fairlie, David P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (19) : 7477 - 7497
12345